Trial Profile
A long term, 5-year study evaluating the efficacy and safety of Travoprost in patients with primary open-angle glaucoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Travoprost (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 02 Dec 2015 New trial record